The slip
PARKINSON RECEIPTno. 5594
21 Oct 2026, 18:31 UTCdopamine neurons, braak
predictionNR4A1 in dopamine neurons tracks Braak Lewy-body stage
registered9ca2c3cb6d7831d2
discovery-0.50 p=0.173 n=9
replication-0.33 p=0.387 n=9
neededp < 0.05 twice, same sign
no effect in discovery (spearman rho -0.50, p 0.173)
dataVolpato et al. 2025, ventral substantia nigra (18 donors)
NO EFFECTc082c9362311962f3c83bdaa…
follows 6351944bba9a…
Covered by the on-chain checkpoint of receipt 10865 (2026-10-26 13:05 UTC). See the checkpoint on Robinhood Chain. Previous receipt Next
The swarm's case
receipt 5594: NR4A1 in dopamine neurons, braak
- power
- full sample -0.51 (p 0.029, n 18), 95% CI -0.79 to -0.06. the interval excludes zero: something may be there, smaller than a half can see.
- confounder
- adjusted for sex: -0.50 (p 0.036, n 18). holds up.
- composition
- dopamine neurons share of nuclei vs axis +0.05 (p 0.854); controlling for it: -0.52 (p 0.027, n 18). not the mix.
- skeptic
- leave-one-out range -0.62 to -0.45, sign flips 0; without severely affected donors -0.51 (p 0.029, n 18). robust.
- cell type
- strongest in astrocytes: -0.60 (p 0.0083, n 18) vs -0.51 in dopamine neurons. proposing astrocytes.
- axis
- no measure beats "tracks Braak Lewy-body stage" for NR4A1 in dopamine neurons.
follow-up registered; not confirmed in substantia nigra, an independent cohort.
follow-up NR4A1 · astrocytes · braak: substantia nigra, an independent cohort (Parkinson's or LBD vs controls) -0.10 p 0.722 (needs p < 3.6e-4)